Literature DB >> 8505073

The detection of HIV-2 infection in southern India.

P G Babu1, N K Saraswathi, F Devapriya, T J John.   

Abstract

To determine the prevalence of HIV-2 infection in southern India, we tested two sets of sera, selected from among the samples which had been collected between January 1988 and October 1990 from high risk subjects and tested for HIV-1 antibody. They were screened for HIV-2 antibody by ELISA and repeatedly reactive sera confirmed by HIV-2 Western blot and line immunoassay. In the first set of 604 sera, only one (0.16%) was positive for HIV-2. In the second set of 24 sera, selected on the basis of having indeterminate HIV-1 Western blot profiles, again one (4%) was positive for HIV-2. The two HIV-2 infected subjects were residents of Madras or Visakhapatnam. Residents of Vellore region constituted 88 and 75 per cent of the two sets of subjects; none was positive for HIV-2. Our results show the prevalence of HIV-2 in the port-cities of southern India. Since it will spread to other regions continuous monitoring for this infection is essential in order to determine when to establish HIV-2 screening in addition to the existing HIV-1 screening of donor blood for transfusion.

Entities:  

Keywords:  Asia; Developing Countries; Diseases; Examinations And Diagnoses; Hiv Infections; Hiv Serodiagnosis; India; Laboratory Examinations And Diagnoses; Laboratory Procedures; Research Report; Southern Asia; Viral Diseases

Mesh:

Substances:

Year:  1993        PMID: 8505073

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  8 in total

1.  Location, exposure, and conservation of neutralizing and nonneutralizing epitopes on human immunodeficiency virus type 2 SU glycoprotein.

Authors:  A McKnight; C Shotton; J Cordell; I Jones; G Simmons; P R Clapham
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

2.  Performance of a rapid immunochromatographic screening test for detection of antibodies to human immunodeficiency virus type 1 (HIV-1) and HIV-2: experience at a tertiary care hospital in South India.

Authors:  Theophilus-Sunder Vijayakumar; Shoba David; Kavitha Selvaraj; Thiruppavai Viswanathan; Rajesh Kannangai; Gopalan Sridharan
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  Molecular confirmation of human immunodeficiency virus (HIV) type 2 in HIV-seropositive subjects in south India.

Authors:  R Kannangai; S Ramalingam; K J Prakash; O C Abraham; R George; R C Castillo; D H Schwartz; M V Jesudason; G Sridharan
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

4.  Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo.

Authors:  J D Reeves; S Hibbitts; G Simmons; A McKnight; J M Azevedo-Pereira; J Moniz-Pereira; P R Clapham
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

5.  Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene.

Authors:  Sabelle Jallow; Steve Kaye; Martin Schutten; Eleonor Brandin; Jan Albert; Samuel J McConkey; Tumani Corrah; Hilton Whittle; Guido Vanham; Sarah Rowland-Jones; Wouter Janssens
Journal:  J Clin Microbiol       Date:  2007-02-28       Impact factor: 5.948

6.  Clinico-epidemiological and Socio-behavioral Study of People Living with HIV/AIDS.

Authors:  M A Khan; A Sehgal
Journal:  Indian J Psychol Med       Date:  2010-01

7.  Characteristics, immunological response & treatment outcomes of HIV-2 compared with HIV-1 & dual infections (HIV 1/2) in Mumbai.

Authors:  Montaldo Chiara; Zachariah Rony; Mansoor Homa; Varghese Bhanumati; Joanna Ladomirska; M Manzi; N Wilson; Deshpande Alaka; A D Harries
Journal:  Indian J Med Res       Date:  2010-12       Impact factor: 2.375

8.  Phylogenetic Analysis of Human Immunodeficiency Virus Type 2 Group B.

Authors:  Eleonora Cella; Alessandra Lo Presti; Marta Giovanetti; Carla Veo; Alessia Lai; Giordano Dicuonzo; Silvia Angeletti; Marco Ciotti; Gianguglielmo Zehender; Massimo Ciccozzi
Journal:  J Glob Infect Dis       Date:  2016 Jul-Sep
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.